Betaxolol (systemic) vs Sulfonylureas

Interacting Drugs
Betaxolol (systemic)
vs
Sulfonylureas
Security Level
Minor, Monitor Therapy
Mechanism
Sulfonylureas: Beta-Blockers may enhance the hypoglycemic effect of Sulfonylureas. Cardioselective beta-blockers (eg, acebutolol, atenolol, metoprolol, and penbutolol) may be safer than nonselective beta-blockers. All beta-blockers appear to mask tachycardia as an initial symptom of hypoglycemia. Ophthalmic beta-blockers are probably associated with lower risk than systemic agents.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Betaxolol (systemic) vs Sulfonylureas